<p>Cells were exposed to GCDCA (50 µmol/L) for 4–16 hrs. Metformin (1 mmol/L) was added 10 minutes before addition of GCDCA. Cells stimulated with H<sub>2</sub>O<sub>2</sub> (5 mmol/L, 6 hrs) were used as positive control. Sytox green nuclear staining was used to determine necrotic cell death. N = 5. Representative images 4 hrs and 16 hrs after stimulation are shown, percentages in panels indicate % of necrotic cells. Upper panel: phase contrast. Lower panel: fluorescence. Magnification 10X.</p
<p><b>A.</b> After 48 hour treatments with metformin (5 mM, +) or control vehicle (H<sub>2</sub>O, –...
<p>Rat hepatocytes were treated without (control) or with GCDCA (50 µmol/L) for 4 hrs (A). GCDCA-tre...
<p>Differentiated C2C12 were pretreated with metformin at different concentrations (0.05, 0.1, 0.2, ...
<p><b>(A-B)</b> 7721 and HepG2 cells were treated with metformin for different time points up to 96 ...
<p>(<b>A–C</b>) MCF-7 cells exposed to 10 mM metformin for 48 and 72 hours were analyzed with flow c...
<p>MCF-7 cells were treated with metformin (10 mM for 24, 48 and 72 hours). DNA cell cycle was analy...
<p>MCF7 cells were plated in MEM medium at different densities from 2X10<sup>5</sup> to 16X10<sup>5<...
<p>MCF7 cells were plated at 8X10<sup>5</sup> cells/well in 6-well plates in MEM medium with 5.5 mM ...
Accumulating evidence suggests that metformin, used as an antidiabetic drug, possesses anti-cancer p...
<p>(A) 24 h after the addition of 5 mM metformin and 5 mM AICAR, the effect of metformin on colorect...
<p>(<b>A</b>) Quantification of apoptotic and necrotic cell death, using flow cytometry and Annexin-...
<p>(<b>A</b>) Western blot of p27 and β-actin from MCF-7 cells that were treated with metformin (10 ...
<p>Comparative FACS analysis following GaPc-PDT + Metformin treatment versus controls in WM35 (a) an...
<p>Primary rat hepatocytes were exposed to GCDCA (50 µmol/L) without or in combination with metformi...
<p>(<b>A–C</b>) MCF-7 cells were treated with metformin (10 mM) for 48 and 72 hours and ROS was dete...
<p><b>A.</b> After 48 hour treatments with metformin (5 mM, +) or control vehicle (H<sub>2</sub>O, –...
<p>Rat hepatocytes were treated without (control) or with GCDCA (50 µmol/L) for 4 hrs (A). GCDCA-tre...
<p>Differentiated C2C12 were pretreated with metformin at different concentrations (0.05, 0.1, 0.2, ...
<p><b>(A-B)</b> 7721 and HepG2 cells were treated with metformin for different time points up to 96 ...
<p>(<b>A–C</b>) MCF-7 cells exposed to 10 mM metformin for 48 and 72 hours were analyzed with flow c...
<p>MCF-7 cells were treated with metformin (10 mM for 24, 48 and 72 hours). DNA cell cycle was analy...
<p>MCF7 cells were plated in MEM medium at different densities from 2X10<sup>5</sup> to 16X10<sup>5<...
<p>MCF7 cells were plated at 8X10<sup>5</sup> cells/well in 6-well plates in MEM medium with 5.5 mM ...
Accumulating evidence suggests that metformin, used as an antidiabetic drug, possesses anti-cancer p...
<p>(A) 24 h after the addition of 5 mM metformin and 5 mM AICAR, the effect of metformin on colorect...
<p>(<b>A</b>) Quantification of apoptotic and necrotic cell death, using flow cytometry and Annexin-...
<p>(<b>A</b>) Western blot of p27 and β-actin from MCF-7 cells that were treated with metformin (10 ...
<p>Comparative FACS analysis following GaPc-PDT + Metformin treatment versus controls in WM35 (a) an...
<p>Primary rat hepatocytes were exposed to GCDCA (50 µmol/L) without or in combination with metformi...
<p>(<b>A–C</b>) MCF-7 cells were treated with metformin (10 mM) for 48 and 72 hours and ROS was dete...
<p><b>A.</b> After 48 hour treatments with metformin (5 mM, +) or control vehicle (H<sub>2</sub>O, –...
<p>Rat hepatocytes were treated without (control) or with GCDCA (50 µmol/L) for 4 hrs (A). GCDCA-tre...
<p>Differentiated C2C12 were pretreated with metformin at different concentrations (0.05, 0.1, 0.2, ...